159 related articles for article (PubMed ID: 2733455)
21. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
22. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
23. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia.
Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
Mills KI; Sproul AM; Burnett AK
Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
[TBL] [Abstract][Full Text] [Related]
25. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
Nishigaki H; Misawa S; Inazawa J; Abe T
Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
[TBL] [Abstract][Full Text] [Related]
26. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
27. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
28. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
Laneuville P; Sullivan AK
Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
[TBL] [Abstract][Full Text] [Related]
29. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
30. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
[TBL] [Abstract][Full Text] [Related]
32. [Rearrangement and expression of bcr-abl genes in CML and ALL].
Kunieda Y; Okabe M
Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738
[TBL] [Abstract][Full Text] [Related]
33. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
34. Long-template DNA polymerase chain reaction for the detection of the bcr/abl translocation in patients with chronic myelogenous leukemia.
Waller CF; Dennebaum G; Feldmann C; Lange W
Clin Cancer Res; 1999 Dec; 5(12):4146-51. PubMed ID: 10632353
[TBL] [Abstract][Full Text] [Related]
35. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
36. Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia.
Romero P; Beran M; Shtalrid M; Andersson B; Talpaz M; Blick M
Oncogene; 1989 Jan; 4(1):93-8. PubMed ID: 2915904
[TBL] [Abstract][Full Text] [Related]
37. [Ph1-positive leukemia: cytogenetic outline and prognosis].
Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
[TBL] [Abstract][Full Text] [Related]
38. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
[TBL] [Abstract][Full Text] [Related]
39. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
Chen S
Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
[TBL] [Abstract][Full Text] [Related]
40. Absence of bcr rearrangement and bcr/abl RNA in a patient with a 31-year survival of CML.
Sproul AM; Mills KI; McDonald GA; Burnett AK
Leukemia; 1990 Jun; 4(6):450-1. PubMed ID: 2359345
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]